scispace - formally typeset
G

Gulnara A. Gaynanova

Researcher at Kazan Federal University

Publications -  10
Citations -  230

Gulnara A. Gaynanova is an academic researcher from Kazan Federal University. The author has contributed to research in topics: Liposome & Cationic liposome. The author has an hindex of 5, co-authored 10 publications receiving 103 citations.

Papers
More filters
Journal ArticleDOI

Self-Assembly of Amphiphilic Compounds as a Versatile Tool for Construction of Nanoscale Drug Carriers.

TL;DR: Different combinations of cyclodextrin platform conjugated with polymers is considered as drug delivery systems with synergetic effect that improves solubility, targeting and biocompatibility of formulations.
Journal ArticleDOI

Biomedical potentialities of cationic geminis as modulating agents of liposome in drug delivery across biological barriers and cellular uptake.

TL;DR: Hydroxyethyl bearing gemini surfactants were used to augment phosphatidylcholine based liposomes to achieve higher stability and enhanced cellular uptake and penetration, and liposomal 2-PAM was found to reactivate 27% of brain acetylcholinesterase, which is, to the authors' knowledge, the first example of such high degree of reactivation after intravenous administration ofliposomal drug.
Journal ArticleDOI

Alkyl triphenylphosphonium surfactants as nucleic acid carriers: complexation efficacy toward DNA decamers, interaction with lipid bilayers and cytotoxicity studies

TL;DR: It was demonstrated that the cytotoxicity of TPPB-n in terms of the MTT-test on a human cell line 293T nonmonotonically changes within the homological series, with the highest cytot toxicity exhibited by the dodecyl and tetradecyl homologs.
Journal ArticleDOI

Comparative study of cationic liposomes modified with triphenylphosphonium and imidazolium surfactants for mitochondrial delivery

TL;DR: It is demonstrated how the positively charged targeting moieties can be exploited to achieve outstanding mitochondria colocalization with a comparative study of n-tetradecyltriphenylphosphonium bromide and 1-(2-hydroxyethyl)-3- tetradecyl-1H-imidazol-3-ium b romide modified liposomes.